Published in J Invest Dermatol on October 01, 1992
Risks and benefits of testosterone therapy in older men. Nat Rev Endocrinol (2013) 2.47
The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci (2011) 2.44
Leptin modulates the effects of acyl CoA:diacylglycerol acyltransferase deficiency on murine fur and sebaceous glands. J Clin Invest (2002) 1.58
Isotretinoin and FoxO1: A scientific hypothesis. Dermatoendocrinol (2011) 1.02
An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinol (2011) 1.02
c-MYC-induced sebaceous gland differentiation is controlled by an androgen receptor/p53 axis. Cell Rep (2013) 0.97
"Sebocytes' makeup": novel mechanisms and concepts in the physiology of the human sebaceous glands. Pflugers Arch (2011) 0.87
Culture of human sebocytes in vitro. Dermatoendocrinol (2009) 0.78
Cidea control of lipid storage and secretion in mouse and human sebaceous glands. Mol Cell Biol (2014) 0.77
Profile of clindamycin phosphate 1.2%/benzoyl peroxide 3.75% aqueous gel for the treatment of acne vulgaris. Clin Cosmet Investig Dermatol (2015) 0.75
The scientific legacy of Stephen Rothman. J Invest Dermatol (2014) 0.75
Other functions, other genes: alternative activation of antigen-presenting cells. Immunity (1999) 4.15
Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J Immunol (1998) 2.17
Alternative versus classical activation of macrophages. Pathobiology (1999) 2.14
Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma. Lancet (1997) 1.98
Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand J Immunol (2001) 1.86
A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris. J Eur Acad Dermatol Venereol (2006) 1.78
The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J Invest Dermatol (2001) 1.67
Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol (1992) 1.47
Differences in angiogenic potential of classically vs alternatively activated macrophages. Immunobiology (1997) 1.44
Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol (1999) 1.43
Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J (1997) 1.43
What is the pathogenesis of acne? Exp Dermatol (2005) 1.40
European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol (2012) 1.40
Intravascular coagulation necrosis of the skin associated with cryofibrinogenemia, diabetes mellitus, and cardiolipin autoantibodies. J Am Acad Dermatol (1991) 1.39
Leptin promotes a proinflammatory lipid profile and induces inflammatory pathways in human SZ95 sebocytes. Br J Dermatol (2014) 1.39
[Acute generalized exanthematous pustulosis, induced by nystatin]. Hautarzt (1998) 1.38
Oral hairy leukoplakia in 71 HIV-seropositive patients: clinical symptoms, relation to immunologic status, and prognostic significance. J Am Acad Dermatol (1996) 1.38
[Combination of interferon-alpha with cytostatic drugs: a potentially successful therapeutic approach in metastatic melanoma]. Hautarzt (1992) 1.38
Outcomes of cryosurgery in keloids and hypertrophic scars. A prospective consecutive trial of case series. Arch Dermatol (1993) 1.36
Current use and future potential role of retinoids in dermatology. Drugs (1997) 1.35
Alterations of cell surfaces as a pathogenetic factor in psoriasis. Possible loss of contact inhibition of growth. Arch Dermatol (1973) 1.31
Elevated plasma levels of transforming growth factor (TGF)-beta1 and TGF-beta2 in patients with disseminated malignant melanoma. Br J Cancer (1998) 1.28
Oral retinoids--present status. Br J Dermatol (1980) 1.26
Cytokine regulation of proliferation and ICAM-1 expression of human dermal microvascular endothelial cells in vitro. J Invest Dermatol (1992) 1.25
Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro. Immunology (1997) 1.24
Evidence for anti-inflammatory activities of oral synthetic retinoids: experimental findings and clinical experience. Br J Dermatol (1983) 1.24
Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus (1997) 1.23
13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. J Invest Dermatol (2000) 1.21
Generalized lichen nitidus. J Am Acad Dermatol (1997) 1.19
Molecular mechanisms of skin aging: state of the art. Ann N Y Acad Sci (2007) 1.18
Growth control of melanoma cells and melanocytes by cytokines. Recent Results Cancer Res (1995) 1.18
Clonal T-cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in advanced cutaneous T-cell lymphoma: a critical evaluation. J Pathol (1999) 1.18
Translation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitro. Int J Cancer (1997) 1.17
Mucocutaneous criteria for the diagnosis of Behçet's disease: an analysis of clinicopathologic data from multiple international centers. J Am Acad Dermatol (1995) 1.16
Matting of hair: a multifactorial enigma. Dermatology (2000) 1.16
Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer (1995) 1.15
Dermal and epidermal types of erythema multiforme. A histopathologic study of 24 cases. Arch Dermatol (1974) 1.15
Vitamins as hormones. Horm Metab Res (2007) 1.14
Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+3, MS-1+/-, 25F9-) in psoriatic dermis. Arch Dermatol Res (1996) 1.13
Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer (1995) 1.12
Kaposi's sarcoma is an important risk factor for survival in HIV-infected patients independent of CD4+ cell count. AIDS (1999) 1.09
Hair destroying growth of Corynebacterium tenuis in the so-called trichomycosis axillaris. New findings from scanning electron microscopy. Arch Dermatol (1971) 1.09
Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release. FEBS Lett (2000) 1.08
Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors. AIDS (1997) 1.07
The plasma unit membrane. Membrane mediated growth control and its failure in psoriasis. Br J Dermatol (1977) 1.07
Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials. J Eur Acad Dermatol Venereol (2012) 1.06
Induction of ceramide-mediated apoptosis by the anticancer phospholipid analog, hexadecylphosphocholine. J Biol Chem (1998) 1.06
Sebocytes are the key regulators of androgen homeostasis in human skin. J Invest Dermatol (2001) 1.05
Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol (1993) 1.04
Current concepts in the treatment of recurrent aphthous stomatitis. Skin Therapy Lett (2008) 1.04
Non-specific lymphocyte transformation in vitro by nickel acetate. A possible source of errors in lymphocyte transformation test (LLT). J Invest Dermatol (1970) 1.02
Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype. J Invest Dermatol (1990) 1.02
[Acquired reactive perforating dermatosis. Successful treatment with allopurinol in 2 cases]. Hautarzt (1999) 1.01
Practical aspects of management of recurrent aphthous stomatitis. J Eur Acad Dermatol Venereol (2007) 1.01
[Beneficial effect of oral retinoid in psoriatic hyperproliferation. Autoradiographic studies on involved and non involved skin (author's transl)]. Arch Dermatol Res (1979) 1.00
Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients. Acta Derm Venereol (1997) 1.00
Kaposi's sarcoma in AIDS. Multicentric angioneoplasia in early skin lesions. Am J Dermatopathol (1987) 1.00
[Netherton's syndrome. Ichthyosis-like changes in the skin and trichorrhexis invaginata. Demonstration of pathologically changed cortex keratin in the hair]. Hautarzt (1971) 0.99
Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol (2013) 0.99
Maintenance of human skin in organ culture: role for insulin-like growth factor-1 receptor and epidermal growth factor receptor. Arch Dermatol Res (1999) 0.99
Electron microscopic study of bullous pemphigoid. Arch Dermatol (1972) 0.99
An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study. Br J Dermatol (2012) 0.98
Ultrastructure and cytochemistry of human cutaneous nerves. With special reference to the ultrastructural localization of the specific and nonspecific cholinesterases in human skin. J Invest Dermatol (1973) 0.98
Tumor necrosis factor-alpha inhibits cell proliferation and induces class II antigens and cell adhesion molecules in cultured normal human keratinocytes in vitro. Arch Dermatol Res (1990) 0.98
Ultrastructural evidence suggesting an immunomodulatory activity of oral retinoid. Its effect on dermal components in psoriasis. Br J Dermatol (1981) 0.98
Expression of vascular endothelial growth factor (VEGF) in various compartments of the human hair follicle. Arch Dermatol Res (1998) 0.98
The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology (1998) 0.97
[Treatment of psoriasis using vitamin A, vitamin A acid and oral retinoids]. Hautarzt (1979) 0.97
Involvement of the corticotropin-releasing hormone system in the pathogenesis of acne vulgaris. Br J Dermatol (2008) 0.96
Testosterone metabolism to 5alpha-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferator-activated receptor ligand linoleic acid in human sebocytes. Br J Dermatol (2007) 0.96
Elephantiasis nostras verrucosa: beneficial effect of oral etretinate therapy. Br J Dermatol (1992) 0.96
Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases. J Am Acad Dermatol (1991) 0.95
Fulminant metastatic calcinosis with cutaneous necrosis in a child with end-stage renal disease and tertiary hyperparathyroidism. Br J Dermatol (1996) 0.95
[Membrane defect as a basic disorder of the growth control mechanism in psoriasis pathogenetic concept and therapeutic consequences (author's transl)]. Dermatologica (1975) 0.94
[Epidemiology and clinical aspects of Adamantiades-Behçet disease in Gemany. Current data]. Ophthalmologe (2012) 0.93
[Oral therapy of psoriasis using two vitamin A acid-derivatives (author's transl)]. Arch Dermatol Forsch (1973) 0.93
Downregulation of cell cycle modulators p21, p27, p53, Rb and proapoptotic Bcl-2-related proteins Bax and Bak in cutaneous melanoma is associated with worse patient prognosis: preliminary findings. J Cutan Pathol (2007) 0.92
Evidence for phosphorylation of CTP:phosphocholine cytidylyltransferase by multiple proline-directed protein kinases. J Biol Chem (1996) 0.92
What causes hidradenitis suppurativa? Exp Dermatol (2008) 0.92
The bisphosphonate pamidronate induces apoptosis in human melanoma cells in vitro. Br J Cancer (2002) 0.92
Treatment of Adamantiades-Behçet disease with systemic interferon alfa. Arch Dermatol (1998) 0.91
Antigen mimicry, epitope spreading and the pathogenesis of pemphigus. Tissue Antigens (2006) 0.91
Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials. J Am Acad Dermatol (1997) 0.91
[Pathogenesis of pemphigus erythematosus. Transformation of a chronic discoid erythematosus in a pemphigus erythematosus (Senear-Usher)]. Arch Dermatol Forsch (1971) 0.91
Monoclonal antibody labeling for cytokeratins and filaggrin in the human pilosebaceous unit of normal, seborrhoeic and acne skin. J Invest Dermatol (1988) 0.91
Metastatic Crohn's disease of the face. J Am Acad Dermatol (1996) 0.91
Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro. Anticancer Res (1995) 0.91
Effects of interferons on cultured human melanocytes in vitro: interferon-beta but not-alpha or -gamma inhibit proliferation and all interferons significantly modulate the cell phenotype. J Invest Dermatol (1991) 0.91
Effects of rIFN alpha, beta, and gamma on the morphology, proliferation, and cell surface antigen expression of human dermal microvascular endothelial cells in vitro. J Invest Dermatol (1990) 0.91
Is acne vulgaris a genuine inflammatory disease? Dermatology (2001) 0.90
Bodybuilder oleoma. Br J Dermatol (2003) 0.90
Extrinsic ageing in the human skin is associated with alterations in the expression of hyaluronic acid and its metabolizing enzymes. Exp Dermatol (2009) 0.90
Helicobacter pylori infection and chronic urticaria. J Am Acad Dermatol (1996) 0.90
Effects of recombinant tumor necrosis factor-alpha on cultured microvascular endothelial cells derived from human dermis. J Invest Dermatol (1990) 0.90